References
- Ondetti M. A., Rubin B., Cushman D. W. Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents. Science 1977; 196: 441–444
- Petrillo E. W., Ondetti M. A. Angiotensin Converting Enzyme Inhibitors: Medicinal Chemistry and Biological Actions. Med. Res. Revs. 1982; 2: 1–41
- Wyvratt M. J., Patchett A. A. Recent Developments in the Design of Angiotensin-Converting Enzyme Inhibitors. Med. Res. Revs. 1985; 5: 483–531
- Monzingo A. F., Matthews B. W. Structure of a Mercaptan-Thermolysin Complex Illustrates Mode of Inhibition of Zinc Proteases by Substrate-Analogue Mercaptans. Biochemistry 1982; 21: 3390–3394
- Monzingo A. F., Matthews B. W. Binding of N-Carboxymethyl Dipeptides Inhibitors to Thermolysin Determined By X-Ray Crystallography: A Novel Class of Transition-State Analogues for Zinc Peptidases. Biochemistry 1984; 23: 5724–5729
- Petrillo E. W., Cushman D. W., Duggan M. E., Heikes J. E., Karanewsky D. S., Ondetti M. A., O'Reilly B., Rovnyak G. C, Schwartz J., Spitzmiller E. R., Wang N. ACE Inhibitors: Phosphinic Acid Analogs of Acyl Tripeptides in Peptides, Structure and Function. Pierce Chemical Co., Rockford, Ill. 1983; 541
- Powell J. R., DeForrest J. M., Cushman D. W., Rubin B., Petrillo E. W. Antihypertensive Effects of a New ACE Inhibitor, SQ 28, 555. Fed. Proc 1984; 43: 733
- Duchin K., Tu J., Frantz M., Willard D. Pharmacodynamics and Pharmacokinetics of SQ 28, 555, A New ACE Inhibitor, in Healthy Subjects. Clin. Pharm. Exp. Ther. 1985; 37: 192
- Almquist R. G., Chao W. R., Ellis M. E., Johnson H. L. Synthesis and Biological Activity of a Ketomethylene Analogue of a Tripeptide Inhibitor of Angiotensin Converting Enzyme. J. Med. Chem. 1980; 23: 1392–1398
- Natarajan S., Gordon E. M., Sabo E. F., Godfrey J. D., Weller H. N., Pluscec J., Rom M. B., Cushman D. W. Ketomethyldipeptides I. A New Class of Angiotensin-Converting Enzyme Inhibitors. Biochem. Biophys. Res. Commun. 1984; 124: 141–147
- Gordon E. M., Natarajan S., Pluscec J., Weller H. N., Godfrey J. D., Rom M. B., Sabo E. F., Engebrecht J., Cushman D. W. Ketomethyldipeptides II. Effect of Modifications of the a-aminoketone Portion on Inhibition of Angiotensin-Converting Enzyme. Biochem. Biophys. Res. Commun. 148–155
- Gordon E. M., Godfrey J. D., Pluscec J., VonLangen D., Natarajan S. Design of Peptide Derived Amino Alcohols as Transition-State Analog Inhibitors of ACE. Biochem. Biophys. Res. Commun. 1985; 126: 419–426
- Natarajan S., Gordon E. M., Sabo E. F., Godfrey J. D., Weller H. N., Pluscec J., Rom M. B., Engebrecht J., Cushman D. W. Ketomethylureas. A New Class of Angiotensin-Converting Enzyme Inhibitors. Abstracts 190th. ACS Natioanl Meeting. 1985, Medi 70
- Almquist R. G., Steeger T., Jackson S., Mitoma C. Absorption, Metabolism, and Excretion Studies of 14C- and 3H-Labeled Derivatives of a Ketomethylene Containing Tripeptide. Life Sci. 1985; 37: 299–305
- Dean A. V., Kripalani K. J., Migdalof B. H. Validation of Bile Duct-Cannulated Rats as a Model for Estimating Oral Absorption of an ACE Inhibitor, SQ 28, 18214C, in Intact Rats. The Pharmacologist 1985; 27: 851